X. Khawaja et al., CHARACTERIZATION OF THE BINDING OF [H-3] WAY-100635, A NOVEL 5-HYDROXYTRYPTAMINE(1A) RECEPTOR ANTAGONIST, TO RAT-BRAIN, Journal of neurochemistry, 64(6), 1995, pp. 2716-2726
The specific binding of [H-3]WAY-100635 {N-[2- ethoxyphenyl)-1-piperaz
inyl]ethyl]-N-(2-pyridinyl) cyclohexane carboxamide trihydrochloride}
to rat hippocampal membrane preparations was time, temperature, and ti
ssue concentration dependent. The rates of [H-3]WAY-100635 association
(k(+1) = 0.069 +/- 0.015 nM(-1) min(-1)) and dissociation (k(-1) = 0.
023 +/- 0.001 min(-1)) followed monoexponential kinetics, Saturation b
inding isotherms of [H-3]WAY-100635 exhibited a single class of recogn
ition site with an affinity of 0.37 +/- 0.051 nM and a maximal binding
capacity (B-max) of 312 +/- 12 fmol/mg of protein, The maximal number
of binding sites labelled by [H-3]WAY-100635 was similar to 36% highe
r compared with that of 8-hydroxy-2-(di-n-[H-3]-propylamino)tetralin (
[H-3]8-OH-DPAT). The binding affinity of [3H]WAY-100635 was significan
tly lowered by the divalent cations CaCl2 (2.5-fold; p < 0.02) and MnC
l2 (3.6-fold; p < 0.05), with no effect on B-max. Guanyl nucleotides f
ailed to influence the K-D and B-max parameters of [H-3]WAY-100635 bin
ding to 5-HT1A receptors, The pharmacological binding profile of [H-3]
WAY-100635 was closely correlated with that of [H-3]8-OH-DPAT, which i
s consistent with the labelling of 5-hydroxytryptamine(1A) (5HT(1A)) s
ites in rat hippocampus. [H-3]WAY-100635 competition curves with 5-HT1
A agonists and partial agonists were best resolved into high- and low-
affinity binding components, whereas antagonists were best described b
y a one-site binding model. In the presence of 50 mu M guanosine 5'-O-
(3-thiotriphosphate) (GTP gamma S), competition curves for the antagon
ists remained unaltered, whereas the agonist and partial agonist curve
s were shifted to the right, reflecting an influence of G protein coup
ling on agonist versus antagonist binding to the 5-HT1A receptor, Howe
ver, a residual (16 +/- 2%) high-affinity agonist binding component wa
s still apparent in the presence of GTP gamma S, indicating the existe
nce of GTP-insensitive sites.